IUPACName
P37377
predicate
Indicates the standardized chemical name assigned to a substance according to IUPAC nomenclature rules.
All labels observed (4)
| Label | Occurrences |
|---|---|
| hasIUPACName | 59 |
| chemicalName | 16 |
| IUPACName canonical | 11 |
| IUPACNamePattern | 1 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: IUPACName
Generated description
Indicates the standardized chemical name assigned to a substance according to IUPAC nomenclature rules.
Sample triples (87)
| Subject | Object |
|---|---|
|
nobelium
surface form:
Nobelium
|
nobelium self-linksurface differs ⓘ |
| lawrencium | lawrencium via predicate surface "hasIUPACName" self-link ⓘ |
| mendelevium | mendelevium self-link ⓘ |
| THC | tetrahydrocannabinol via predicate surface "chemicalName" ⓘ |
| THC | (−)-trans-Δ⁹-tetrahydrocannabinol ⓘ |
|
essential amino acid tryptophan
surface form:
tryptophan
|
(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid via predicate surface "hasIUPACName" ⓘ |
|
VX gas
surface form:
VX
|
O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothioate ⓘ |
| zanamivir | (2R,3R,4S)-4-guanidino-3-acetamido-2-[(1R,2R)-1,2-dihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid via predicate surface "hasIUPACName" ⓘ |
| einsteinium | einsteinium self-link ⓘ |
| seaborgium | seaborgium self-link ⓘ |
| rivastigmine | (S)-N-ethyl-N-methyl-3-[1-(dimethylamino)ethyl]phenyl carbamate via predicate surface "hasIUPACName" ⓘ |
|
memantine
surface form:
Memantine
|
3,5-dimethyladamantan-1-amine via predicate surface "hasIUPACName" ⓘ |
|
riluzole
surface form:
Riluzole
|
6-(trifluoromethoxy)-1,3-benzothiazol-2-amine via predicate surface "hasIUPACName" ⓘ |
|
edaravone
surface form:
Edaravone
|
3-methyl-1-phenyl-2-pyrazolin-5-one via predicate surface "hasIUPACName" ⓘ |
|
element meitnerium
surface form:
Meitnerium
|
element meitnerium
self-linksurface differs
ⓘ
surface form:
meitnerium
|
| Tyrian purple | 6,6′-dibromoindigo via predicate surface "chemicalName" ⓘ |
| Cocaine | methyl (1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate via predicate surface "hasIUPACName" ⓘ |
| Teflon | polytetrafluoroethylene via predicate surface "chemicalName" ⓘ |
| Neoprene | polychloroprene via predicate surface "chemicalName" ⓘ |
|
Freon
surface form:
Freon-12
|
dichlorodifluoromethane via predicate surface "chemicalName" ⓘ |
|
Freon
surface form:
Freon-11
|
trichlorofluoromethane via predicate surface "chemicalName" ⓘ |
|
Freon
surface form:
Freon-22
|
chlorodifluoromethane via predicate surface "chemicalName" ⓘ |
|
Freon
surface form:
Freon-113
|
1,1,2-trichloro-1,2,2-trifluoroethane via predicate surface "chemicalName" ⓘ |
| amantadine | 1-adamantanamine via predicate surface "hasIUPACName" ⓘ |
| methotrexate | (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid via predicate surface "hasIUPACName" ⓘ |
| warfarin | 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one via predicate surface "hasIUPACName" ⓘ |
| thalidomide | 2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione via predicate surface "hasIUPACName" ⓘ |
| DDT | dichlorodiphenyltrichloroethane via predicate surface "chemicalName" ⓘ |
|
THCA (tetrahydrocannabinolic acid)
surface form:
THCA
|
2-[(1R,3R)-3,7-dimethyl-2,6-dioxo-4-pentyl-1-cyclohexen-1-yl]-5-pentylbenzene-1,3-diol ⓘ |
| rimonabant | 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide via predicate surface "hasIUPACName" ⓘ |
| cyclophosphamide | 2-[bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin-2-oxide via predicate surface "hasIUPACName" ⓘ |
|
docetaxel
surface form:
Docetaxel
|
(2R,3S)-N-carboxy-3-phenylisoserine N-tert-butyl ester, 13-ester with 5β,20-epoxy-1,2α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4-acetate 2-benzoate via predicate surface "hasIUPACName" ⓘ |
| carbolic acid | phenol via predicate surface "hasIUPACName" ⓘ |
| LSD | lysergic acid diethylamide via predicate surface "chemicalName" ⓘ |
| Epsom salts | magnesium sulfate heptahydrate via predicate surface "hasIUPACName" ⓘ |
| NAD+ | β-nicotinamide adenine dinucleotide via predicate surface "hasIUPACName" ⓘ |
|
albendazole
surface form:
Albendazole
|
methyl N-[6-(propylthio)-1H-benzimidazol-2-yl]carbamate via predicate surface "hasIUPACName" ⓘ |
|
H2 receptor antagonist cimetidine
surface form:
cimetidine
|
N-cyano-N'-methyl-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine via predicate surface "hasIUPACName" ⓘ |
| Unh | unnilhexium via predicate surface "IUPACNamePattern" NERFINISHED ⓘ |
| V2O3 | vanadium(III) oxide ⓘ |
| vanadium dioxide | vanadium(IV) oxide via predicate surface "hasIUPACName" ⓘ |
| Fentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide via predicate surface "hasIUPACName" ⓘ |
| 2,4-D | 2,4-dichlorophenoxyacetic acid via predicate surface "chemicalName" ⓘ |
| larotrectinib | (3R)-N-{5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyridin-3-yl}-3-(1H-1,2,4-triazol-1-yl)pyrrolidine-1-carboxamide via predicate surface "hasIUPACName" ⓘ |
| fluconazole | 2-(2,4-difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol via predicate surface "hasIUPACName" ⓘ |
| Arrhenius base | Arrhenius base via predicate surface "hasIUPACName" NERFINISHED ⓘ |
| pimozide | 1-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one via predicate surface "hasIUPACName" ⓘ |
| thioridazine | 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine via predicate surface "hasIUPACName" ⓘ |
| buckminsterfullerene | (C60-Ih)[5,6]fullerene via predicate surface "hasIUPACName" ⓘ |
| Adams catalyst | platinum(IV) oxide hydrate via predicate surface "hasIUPACName" ⓘ |